Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Commitments (Details)

v3.23.1
Commitments (Details) - CAD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments    
payments for activities related to its clinical trial $ 2,701,114 $ 1,613,142